▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

Circus Expands Trading Access to the U.S. Market via ADR Structure

Circus SE (ISIN: DE000A2YN355 / XETRA: CA1), a global AI robotics company, today announced the establishment of a sponsored Level I American Depositary Receipt (ADR) program in the United States. Thro...

Immagine

MUNICH: Circus SE (ISIN: DE000A2YN355 / XETRA: CA1), a global AI robotics company, today announced the establishment of a sponsored Level I American Depositary Receipt (ADR) program in the United States.

Through this ADR structure, Circus shares can now be bought and traded by U.S. investors, settled locally, and held in U.S. brokerage accounts, while the company remains primarily listed on XETRA in Germany.

“The sponsored ADR program supports our objective of expanding our international investor base while maintaining a disciplined and cost-efficient capital market structure,” said Nikolas Bullwinkel, Founder and CEO of Circus. “U.S. investors are showing strong and growing interest in our shares, and this program provides direct access.”

The Circus ADRs are issued by The Bank of New York Mellon (BNY) where each ADR represents one share of Circus. BNY is one of the world’s oldest and leading financial institutions, with more than US$50 trillion in assets under custody.

The ADRs will trade on the U.S. over-the-counter market under the ticker symbol CCUSY and will be quoted and settled in U.S. dollars.

Overview of the ADR Program:

Item

Details

Program Type: Sponsored Level I ADR program

Trading Venue: U.S. Over-the-Counter Market (OTC)

Effective Date (scheduled): January 6, 2026 (U.S. Eastern Time)

ADR-to-Common Share Ratio: 1 ADR = 1 Share

CUSIP Number: 17282L106

ISIN: DE000A2YN355

Ticker Symbol: CCUSY

Depositary Bank: BNY

Custodian Bank in Germany: The Bank of New York Mellon Corporation SA/NV

About Circus SE

Circus SE (XETRA: CA1) is a global AI and robotics company developing autonomous systems for food supply in both civilian and defense sectors. Its flagship robot, the patented CA-1, is the world’s first fully autonomous food production robot, now in serial production. Powered by proprietary embodied AI, Circus delivers industrial-scale, high-reliability meal output with minimal human input. Headquartered in Munich, the company is building the global infrastructure for autonomous food supply – on a mission to fuel humanity.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

Beyond the website: Algolia takes on the Next Era of AI-Driven Retail…

Algolia, the AI Search and Retrieval platform trusted by more than 18,000 businesses and millions of developers worldwide, today announced that Algolia…

Allianz and Anthropic Forge Global Partnership to Advance Responsible…

Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration…

Chai Discovery Announces Collaboration with Eli Lilly and Company to Accelerate…

Chai Discovery, the AI company building a computer-aided design suite for molecules, today announced a collaboration with Eli Lilly and Company (Lilly)…

Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery…

Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!